Susan L. Baldwin

4.0k total citations · 1 hit paper
65 papers, 3.1k citations indexed

About

Susan L. Baldwin is a scholar working on Infectious Diseases, Immunology and Epidemiology. According to data from OpenAlex, Susan L. Baldwin has authored 65 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Infectious Diseases, 37 papers in Immunology and 33 papers in Epidemiology. Recurrent topics in Susan L. Baldwin's work include Tuberculosis Research and Epidemiology (32 papers), Immune Response and Inflammation (18 papers) and Mycobacterium research and diagnosis (16 papers). Susan L. Baldwin is often cited by papers focused on Tuberculosis Research and Epidemiology (32 papers), Immune Response and Inflammation (18 papers) and Mycobacterium research and diagnosis (16 papers). Susan L. Baldwin collaborates with scholars based in United States, Canada and Switzerland. Susan L. Baldwin's co-authors include Rhea N. Coler, Steven G. Reed, Thomas S. Vedvick, Sylvie Bertholet, Ian M. Orme, Christopher B. Fox, Kris Huygen, Jeffrey B. Ulmer, Celine D’Souza and Sasha E. Larsen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Susan L. Baldwin

60 papers receiving 3.1k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Immunogenicity and protective efficacy of a tuberculosis DNA vaccine

1996 541 citations Kris Huygen, Jean Content et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Susan L. Baldwin United States	28	1.8k	1.7k	1.5k	824	174	65	3.1k
Claus Aagaard Denmark	31	2.1k 1.2×	1.6k 0.9×	1.5k 1.0×	1.4k 1.7×	81 0.5×	53	3.5k
Ricardo E. Tascon United Kingdom	22	1.3k 0.7×	1.4k 0.8×	1.0k 0.7×	900 1.1×	317 1.8×	31	2.6k
Mahavir Singh United Kingdom	34	2.4k 1.3×	1.2k 0.7×	1.9k 1.3×	1.5k 1.8×	115 0.7×	139	4.1k
Nathalie Winter France	33	1.6k 0.9×	1.6k 1.0×	1.3k 0.9×	699 0.8×	166 1.0×	72	3.4k
Geetha P. Bansal United States	17	1.6k 0.9×	674 0.4×	1.4k 0.9×	707 0.9×	209 1.2×	43	2.8k
Angelo Izzo United States	28	2.3k 1.3×	1.6k 1.0×	1.4k 1.0×	895 1.1×	61 0.4×	70	3.3k
André Kipnis Brazil	28	1.3k 0.7×	995 0.6×	1.0k 0.7×	523 0.6×	98 0.6×	96	2.6k
Laleh Majlessi France	33	3.1k 1.7×	1.6k 1.0×	2.5k 1.7×	1.1k 1.3×	79 0.5×	77	4.5k
H. Martin Vordermeier United Kingdom	37	2.8k 1.5×	1.4k 0.8×	2.2k 1.5×	861 1.0×	151 0.9×	82	3.5k
Bernardo Villarreal‐Ramos United Kingdom	34	1.9k 1.1×	1.2k 0.7×	1.2k 0.8×	566 0.7×	64 0.4×	87	2.9k

Countries citing papers authored by Susan L. Baldwin

Since Specialization

Citations

This map shows the geographic impact of Susan L. Baldwin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan L. Baldwin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan L. Baldwin more than expected).

Fields of papers citing papers by Susan L. Baldwin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan L. Baldwin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan L. Baldwin. The network helps show where Susan L. Baldwin may publish in the future.

Co-authorship network of co-authors of Susan L. Baldwin

This figure shows the co-authorship network connecting the top 25 collaborators of Susan L. Baldwin. A scholar is included among the top collaborators of Susan L. Baldwin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan L. Baldwin. Susan L. Baldwin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Larsen, Sasha E., Maham Rais, Valerie A. Reese, et al.. (2025). Characterizing TLR4 agonist EmT4™ as an anti-Mycobacterium tuberculosis vaccine adjuvant. ImmunoHorizons. 9(6).

Larsen, Sasha E., et al.. (2024). Backtranslation of human RNA biosignatures of tuberculosis disease risk into the preclinical pipeline is condition dependent. mSphere. 10(1). e0086424–e0086424.

Lyu, Jiwon, Susan L. Baldwin, Sasha E. Larsen, et al.. (2024). Understanding the development of tuberculous granulomas: insights into host protection and pathogenesis, a review in humans and animals. Frontiers in Immunology. 15. 1427559–1427559. 6 indexed citations

Wang, Qixin, et al.. (2024). Antibodies as key mediators of protection against Mycobacterium tuberculosis. Frontiers in Immunology. 15. 1430955–1430955. 4 indexed citations

Kang, Young Ae, Kwang Joo Park, Jae Chol Choi, et al.. (2023). Safety and Immunogenicity of the ID93 + GLA-SE Tuberculosis Vaccine in BCG-Vaccinated Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial. Infectious Diseases and Therapy. 12(6). 1605–1624. 13 indexed citations

Maloney, Sara E., Ian E. Stewart, Brendan K. Podell, et al.. (2023). Preparation Strategies of the Anti-Mycobacterial Drug Bedaquiline for Intrapulmonary Routes of Administration. Pharmaceuticals. 16(5). 729–729. 6 indexed citations

Berube, Bryan J., Sasha E. Larsen, Matthew B. McNeil, et al.. (2022). Characterizing in vivo loss of virulence of an HN878 Mycobacterium tuberculosis isolate from a genetic duplication event. Tuberculosis. 137. 102272–102272. 2 indexed citations

Larsen, Sasha E., et al.. (2022). It Takes a Village: The Multifaceted Immune Response to Mycobacterium tuberculosis Infection and Vaccine-Induced Immunity. Frontiers in Immunology. 13. 840225–840225. 28 indexed citations

Larsen, Sasha E., Valerie A. Reese, Bryan J. Berube, et al.. (2021). Subunit vaccine protects against a clinical isolate of Mycobacterium avium in wild type and immunocompromised mouse models. Scientific Reports. 11(1). 9040–9040. 20 indexed citations

10.

Kwon, Kee Woong, Sasha E. Larsen, Susan L. Baldwin, et al.. (2019). Long-term protective efficacy with a BCG-prime ID93/GLA-SE boost regimen against the hyper-virulent Mycobacterium tuberculosis strain K in a mouse model. Scientific Reports. 9(1). 15560–15560. 37 indexed citations

11.

Carter, Darrick, Neal Van Hoeven, Susan L. Baldwin, et al.. (2018). The adjuvant GLA-AF enhances human intradermal vaccine responses. Science Advances. 4(9). eaas9930–eaas9930. 33 indexed citations

12.

Allen, James D., Simon O. Owino, Donald M. Carter, et al.. (2017). Broadened immunity and protective responses with emulsion-adjuvanted H5 COBRA-VLP vaccines. Vaccine. 35(38). 5209–5216. 20 indexed citations

13.

Baldwin, Susan L., Valerie A. Reese, Po‐Wei Huang, et al.. (2015). Protection and Long-Lived Immunity Induced by the ID93/GLA-SE Vaccine Candidate against a Clinical Mycobacterium tuberculosis Isolate. Clinical and Vaccine Immunology. 23(2). 137–147. 44 indexed citations

14.

Baldwin, Susan L., Valerie A. Reese, Brian Granger, et al.. (2014). The ID93 Tuberculosis Vaccine Candidate Does Not Induce Sensitivity to Purified Protein Derivative. Clinical and Vaccine Immunology. 21(9). 1309–1313. 16 indexed citations

15.

McElhaney, Janet E., Rhea N. Coler, & Susan L. Baldwin. (2013). Immunologic correlates of protection and potential role for adjuvants to improve influenza vaccines in older adults. Expert Review of Vaccines. 12(7). 759–766. 33 indexed citations

16.

Fox, Christopher B., James Chesko, Thomas S. Vedvick, et al.. (2012). Adjuvanted pandemic influenza vaccine: variation of emulsion components affects stability, antigen structure, and vaccine efficacy. Influenza and Other Respiratory Viruses. 7(5). 815–826. 15 indexed citations

17.

Fox, Christopher B., Susan L. Baldwin, Malcolm S. Duthie, Steven G. Reed, & Thomas S. Vedvick. (2012). Immunomodulatory and Physical Effects of Phospholipid Composition in Vaccine Adjuvant Emulsions. AAPS PharmSciTech. 13(2). 498–506. 21 indexed citations

18.

Coler, Rhea N., Susan L. Baldwin, Narek Shaverdian, et al.. (2010). A Synthetic Adjuvant to Enhance and Expand Immune Responses to Influenza Vaccines. PLoS ONE. 5(10). e13677–e13677. 124 indexed citations

19.

Wonderling, R S, Tim D. Powell, Susan L. Baldwin, et al.. (2002). Cloning, expression, purification, and biological activity of five feline type I interferons. Veterinary Immunology and Immunopathology. 89(1-2). 13–27. 21 indexed citations

20.

Huygen, Kris, Jean Content, Olivier Denis, et al.. (1996). Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nature Medicine. 2(8). 893–898. 541 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact